Temperature-dependent structural changes of Parkinson's alpha-synuclein reveal the role of pre-existing oligomers in alpha-synuclein fibrillization
- PMID: 23349712
- PMCID: PMC3551866
- DOI: 10.1371/journal.pone.0053487
Temperature-dependent structural changes of Parkinson's alpha-synuclein reveal the role of pre-existing oligomers in alpha-synuclein fibrillization
Abstract
Amyloid fibrils of α-synuclein are the main constituent of Lewy bodies deposited in substantial nigra of Parkinson's disease brains. α-Synuclein is an intrinsically disordered protein lacking compact secondary and tertiary structures. To enhance the understanding of its structure and function relationship, we utilized temperature treatment to study α-synuclein conformational changes and the subsequent effects. We found that after 1 hr of high temperature pretreatment, >80°C, α-synuclein fibrillization was significantly inhibited. However, the temperature melting coupled with circular dichroism spectra showed that α-synuclein was fully reversible and the NMR studies showed no observable structural changes of α-synuclein after 95°C treatment. By using cross-linking and analytical ultracentrifugation, rare amount of pre-existing α-synuclein oligomers were found to decrease after the high temperature treatment. In addition, a small portion of C-terminal truncation of α-synuclein also occurred. The reduction of pre-existing oligomers of α-synuclein may contribute to less seeding effect that retards the kinetics of amyloid fibrillization. Overall, our results showed that the pre-existing oligomeric species is a key factor contributing to α-synuclein fibrillization. Our results facilitate the understanding of α-synuclein fibrillization.
Conflict of interest statement
Figures








Similar articles
-
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.Biochemistry. 2000 Mar 14;39(10):2552-63. doi: 10.1021/bi991447r. Biochemistry. 2000. PMID: 10704204
-
Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution.Sci Rep. 2019 Feb 11;9(1):1734. doi: 10.1038/s41598-018-37584-6. Sci Rep. 2019. PMID: 30741954 Free PMC article.
-
Modulation of α-synuclein fibrillization by ring-fused 2-pyridones: templation and inhibition involve oligomers with different structure.Arch Biochem Biophys. 2013 Apr 15;532(2):84-90. doi: 10.1016/j.abb.2013.01.012. Epub 2013 Feb 9. Arch Biochem Biophys. 2013. PMID: 23399432
-
Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.Curr Protein Pept Sci. 2010 Aug;11(5):334-42. doi: 10.2174/138920310791330659. Curr Protein Pept Sci. 2010. PMID: 20423294 Review.
-
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373. Mov Disord. 2013. PMID: 23390095 Review.
Cited by
-
A sensitive probe for amyloid fibril detection with strong fluorescence and early response.RSC Adv. 2018 Apr 27;8(29):15870-15875. doi: 10.1039/c8ra00751a. eCollection 2018 Apr 27. RSC Adv. 2018. PMID: 35542196 Free PMC article.
-
Familial Parkinson disease-associated mutations alter the site-specific microenvironment and dynamics of α-synuclein.J Biol Chem. 2015 Mar 20;290(12):7804-22. doi: 10.1074/jbc.M114.598607. Epub 2015 Jan 29. J Biol Chem. 2015. PMID: 25635052 Free PMC article.
-
Photo-Induced Cross-Linking of Unmodified α-Synuclein Oligomers.ACS Chem Neurosci. 2023 Sep 6;14(17):3192-3205. doi: 10.1021/acschemneuro.3c00326. Epub 2023 Aug 24. ACS Chem Neurosci. 2023. PMID: 37621159 Free PMC article.
-
Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity.Commun Biol. 2023 Jul 21;6(1):767. doi: 10.1038/s42003-023-05142-0. Commun Biol. 2023. PMID: 37479809 Free PMC article.
-
Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods.Front Aging Neurosci. 2021 Nov 8;13:759182. doi: 10.3389/fnagi.2021.759182. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34858161 Free PMC article.
References
-
- Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, et al. (1997) [alpha]-Synuclein in Lewy bodies. Nature 388: 839–840. - PubMed
-
- Shulman JM, De Jager PL, Feany MB (2011) Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol 6: 193–222. - PubMed
-
- Bonini NM, Giasson BI (2005) Snaring the function of alpha-synuclein. Cell 123: 359–361. - PubMed
-
- Sidhu A, Wersinger C, Vernier P (2004) Does {alpha}-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J 18: 637–647. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical